Early Discovery
Translatable Discovery
Assay Development
Assay Performance
Biomarker Qualification
Biomarker Validation


Pipeline Overview

The NBDA "modular biomarker development
pipeline": transforming "unsolvable problems"
into standards-based solutions-enabling
precision medicine!


Event Image

NBDA Workshop IV

Challenging Dogma: Creating a New Generation of Efficacious Biomarker-Driven Clinical Trials.
NBDA Workshop IV will be held February 3-4, 2014


Launch of a Transformative Health Care Initiative: The National Biomarker Development Alliance (NBDA)

WASHINGTON, D.C. - The launch of a new independent, non-profit organization, the National Biomarker Development Alliance (NBDA), broadly engaging leaders in industry, academia, patient groups and government from across the country, was announced today at the National Press Club by the Research Collaboratory at Arizona State University (ASU).
Read Press Release >>

January 13, 2014

The Launch of the “National Biomarker Development Alliance (NBDA)” to be held at the National Press Club on January 13, 2014.

About NBDA

Mission: To collaboratively create an evidence-based end-to-end biomarker development process based on standards, best practices, guidelines (inclusive of all phases from early discovery to clinical application).

The NBDA's vision is not to just relegate the current biomarker development processes to history, but also to serve as a working example of what convergence of purpose, scientific knowledge and collaboration can accomplish.